Celestone Soluspan News Today

Blueprint Medicines (NASDAQ:BPMC – Get Rating) and Hypera (OTCMKTS:HYPMY – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Analyst Recommendations This is a summary of current recommendations and price […]

First quarter 2023 revenue of $1,538 millionFirst quarter 2023 diluted earnings per share of $0.69 and non-GAAP Adjusted diluted earnings per share of $1.08Both reported and non-GAAP Adjusted diluted earnings per share include a negative impact of $0.03 per share for acquired in-process research and development (IPR...

Organon (OGN) stock fell ~10% on Thursday after Q1 results. Read more here

Elanco Animal Health (NYSE:ELAN – Get Rating) and Hypera (OTCMKTS:HYPMY – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Institutional & Insider Ownership 0.1% of Hypera shares are held […]

Elanco Animal Health (NYSE:ELAN – Get Rating) and Hypera (OTCMKTS:HYPMY – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, institutional ownership and profitability. Institutional and Insider Ownership 0.1% of Hypera shares are held […]

Hypera (OTCMKTS:HYPMY – Get Rating) and Myovant Sciences (NYSE:MYOV – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation. Risk & Volatility Hypera has a beta of 0.8, suggesting that […]